Product Code: ETC4471659 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The cardiac marker testing market in Turkey is growing as a result of the increasing prevalence of cardiovascular diseases and the need for early diagnosis and treatment. Cardiac marker tests are used to detect specific proteins in the blood that indicate heart damage or stress. The market is driven by advancements in diagnostic technologies, the growing aging population, and the rising awareness of the importance of early detection of heart conditions.
The cardiac marker testing market in Turkey is driven by cardiovascular disease diagnostics, advancements in biomarker technologies, and the demand for early detection tools. Key drivers include innovations in immunoassay and point-of-care testing, the growth of clinical laboratories and hospitals, and investments in medical diagnostics research. Additionally, the adoption of high-sensitivity cardiac troponin tests, regulatory approvals for diagnostic assays, and public health initiatives for heart disease prevention influence market dynamics.
The Cardiac Marker Testing market in Turkey is expanding due to the increasing prevalence of cardiovascular diseases. Challenges include high testing costs and the need for continuous innovation to improve diagnostic accuracy and speed.
Turkey`s cardiac marker testing market is growing with rising prevalence of cardiovascular diseases and aging population. Government healthcare reforms promoting early diagnosis and treatment drive market expansion, focusing on adoption of advanced diagnostic technologies and improvement in patient care outcomes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Turkey Cardiac Marker Testing Market Overview |
3.1 Turkey Country Macro Economic Indicators |
3.2 Turkey Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Turkey Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Turkey Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Turkey Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Turkey Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Turkey Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Turkey Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Turkey Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Turkey |
4.2.2 Growing awareness about the importance of early detection of cardiac conditions |
4.2.3 Technological advancements in cardiac marker testing leading to more accurate and efficient diagnosis |
4.3 Market Restraints |
4.3.1 High cost associated with cardiac marker testing procedures |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Turkey |
4.3.3 Regulatory challenges and compliance requirements in the healthcare industry |
5 Turkey Cardiac Marker Testing Market Trends |
6 Turkey Cardiac Marker Testing Market, By Types |
6.1 Turkey Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Turkey Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Turkey Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.4 Turkey Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Turkey Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Turkey Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Turkey Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Turkey Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Turkey Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Turkey Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Turkey Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Turkey Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Turkey Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Turkey Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Turkey Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Turkey Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Turkey Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Turkey Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Turkey Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Turkey Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Turkey Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Turkey Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Turkey Cardiac Marker Testing Market Export to Major Countries |
7.2 Turkey Cardiac Marker Testing Market Imports from Major Countries |
8 Turkey Cardiac Marker Testing Market Key Performance Indicators |
8.1 Average turnaround time for cardiac marker test results |
8.2 Percentage of hospitals and clinics offering cardiac marker testing services |
8.3 Adoption rate of new cardiac marker testing technologies |
8.4 Patient satisfaction scores related to cardiac marker testing services |
8.5 Number of research studies or publications on cardiac markers in Turkey |
9 Turkey Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Turkey Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Turkey Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Turkey Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Turkey Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Turkey Cardiac Marker Testing Market - Competitive Landscape |
10.1 Turkey Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Turkey Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |